223 related articles for article (PubMed ID: 25754023)
1. Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours.
Packard M; Gayou O; Gurram K; Weiss B; Thakkar S; Kirichenko A
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):499-506. PubMed ID: 25754023
[TBL] [Abstract][Full Text] [Related]
2. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
[TBL] [Abstract][Full Text] [Related]
3. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).
Barney BM; Lee RJ; Handrahan D; Welsh KT; Cook JT; Sause WT
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):301-5. PubMed ID: 20864274
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Bony Anatomy Versus Endobiliary Stents as Surrogates for Volumetric Image Guidance in Pancreatic Cancer.
Chortogiannos C; Moseley D; Chen J; Pellizzari A; Brierley J; Li W
J Med Imaging Radiat Sci; 2017 Dec; 48(4):352-359. PubMed ID: 31047470
[TBL] [Abstract][Full Text] [Related]
5. Potential systematic uncertainties in IGRT when FBCT reference images are used for pancreatic tumors.
Amoush A; Abdel-Wahab M; Abazeed M; Xia P
J Appl Clin Med Phys; 2015 May; 16(3):5257. PubMed ID: 26103487
[TBL] [Abstract][Full Text] [Related]
6. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography.
van der Horst A; Wognum S; Dávila Fajardo R; de Jong R; van Hooft JE; Fockens P; van Tienhoven G; Bel A
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):202-8. PubMed ID: 23790774
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.
van den Ende RPJ; Kerkhof EM; Rigter LS; van Leerdam ME; Peters FP; van Triest B; Staring M; Marijnen CAM; van der Heide UA
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1151-1159. PubMed ID: 31476419
[TBL] [Abstract][Full Text] [Related]
8. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
[TBL] [Abstract][Full Text] [Related]
9. The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.
Thomas M; De Roover R; van der Merwe S; Lambrecht M; Defraene G; Haustermans K
Clin Transl Radiat Oncol; 2021 Jan; 26():8-14. PubMed ID: 33251342
[TBL] [Abstract][Full Text] [Related]
10. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
[TBL] [Abstract][Full Text] [Related]
11. Comparison of kV Orthogonal Radiographs and kV-Cone-Beam Computed Tomography Image-Guided Radiotherapy Methods With and Without Implanted Fiducials in Prostate Cancer.
Eren MF; Çolpan Öksüz D; Sayan M; Karaçam S; Vergalasova I; Ay Eren A; Öner Dinçbaş F
Cureus; 2020 Aug; 12(8):e9916. PubMed ID: 32850264
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric effects of anatomical changes during fractionated photon radiation therapy in pancreatic cancer patients.
van der Horst A; Houweling AC; van Tienhoven G; Visser J; Bel A
J Appl Clin Med Phys; 2017 Nov; 18(6):142-151. PubMed ID: 28980445
[TBL] [Abstract][Full Text] [Related]
13. Interfractional uncertainty in the treatment of pancreatic cancer with radiation.
Jayachandran P; Minn AY; Van Dam J; Norton JA; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):603-7. PubMed ID: 19879062
[TBL] [Abstract][Full Text] [Related]
14. Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.
Sato H; Abe E; Utsunomiya S; Kaidu M; Yamana N; Tanaka K; Ohta A; Obinata M; Liu J; Kawaguchi G; Maruyama K; Ayukawa F; Aoyama H
J Appl Clin Med Phys; 2015 Sep; 16(5):239–245. PubMed ID: 26699304
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT.
Li M; Ballhausen H; Hegemann NS; Reiner M; Tritschler S; Gratzke C; Manapov F; Corradini S; Ganswindt U; Belka C
Strahlenther Onkol; 2017 Mar; 193(3):221-228. PubMed ID: 27928626
[TBL] [Abstract][Full Text] [Related]
16. BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model : Experiences with a liquid fiducial marker.
Dobiasch S; Kampfer S; Burkhardt R; Schilling D; Schmid TE; Wilkens JJ; Combs SE
Strahlenther Onkol; 2017 Dec; 193(12):1039-1047. PubMed ID: 28808749
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cone beam CT registration for prostate radiation therapy: fiducial marker and soft tissue methods.
Deegan T; Owen R; Holt T; Fielding A; Biggs J; Parfitt M; Coates A; Roberts L
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):91-8. PubMed ID: 24953244
[TBL] [Abstract][Full Text] [Related]
18. Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
Yildirim BA; Onal C; Dolek Y
Jpn J Radiol; 2017 Jan; 35(1):3-9. PubMed ID: 27730453
[TBL] [Abstract][Full Text] [Related]
19. Image guided radiation therapy for bladder cancer: assessment of bladder motion using implanted fiducial markers.
Biancia CD; Yorke E; Kollmeier MA
Pract Radiat Oncol; 2014; 4(2):108-115. PubMed ID: 24890351
[TBL] [Abstract][Full Text] [Related]
20. Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared.
van der Horst A; Lens E; Wognum S; de Jong R; van Hooft JE; van Tienhoven G; Bel A
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):641-8. PubMed ID: 24803041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
